251120.KQ Bio-FD&C Co. Ltd.
- Market cap
- KRW 78.0B
- P/E
- 12.2x
- P/B
- 1.07x
- ROE
- 8.6%
- Dividend yield
- -
- Fundamental score
- 2.1/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 251120.KQ undervalued?
Graham number251120.KQ trades 23.7% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Bio-FD&C Co. Ltd. fundamental analysis
11 of 22 checks passedROE 0/2
Low return on equity (8.6%), below 10%.
ROA 1/1
Return on assets (8.2%) is above the industry median (1.4%).
Profit Consistency 2/2
Profitable for 8 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 1/1
Last year's EPS growth (48.1%) is above the 5-year average (22.5% a year).
Earnings Growth vs Industry 1/1
Last year's EPS growth (48.1%) is above the industry median (1.8%).
Revenue Growth 1/2
Revenue grew 6.5% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 0/1
Debt is not reported.
Interest Coverage 1/1
EBIT is 397.4x against interest expense, well covered.
PE vs Market 0/1
PE (12.2x) is above the market median (11.3x).
PE vs Industry 0/1
PE (12.2x) is above the industry median (11.4x).
PBV 0/1
Price to book (1.1x) is above the industry median (0.9x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 13.1, limit 22.5).
PEG 1/1
PEG on 5-year earnings growth is 0.54, growth is cheap.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Bio-FD&C Co. Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Bio-FD&C Co. Ltd.
BIO-FD&C Co.,Ltd. develops active ingredients for anti-aging cosmetics in South Korea. It offers plant cell, peptide, natural extract, and biomolecule products for wrinkle improvement/skin regeneration, skin brightening, acne, skin irritation, wound healing, scalp improvement, skin moisturizing, fine dust, hair loss improvement, pores, lifting, whitening, skin texture, anti-inflammation/skin soothing, and anti-oxidation. The company was founded in 2005 and is headquartered i…
Full company profileBio-FD&C Co. Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Bio-FD&C Co. Ltd. annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 6.00B | 8.48B | 8.64B | 12.0B | 15.9B | 15.6B | 16.1B | 19.2B | 18.7B |
| Gross Profit | 3.00B | 5.65B | 5.64B | 7.13B | 11.0B | 11.0B | 11.2B | 12.9B | 13.1B |
| Operating Income | 238M | 2.90B | 2.92B | 3.14B | 4.88B | 5.03B | 4.85B | 6.25B | 6.26B |
| EBITDA | - | - | - | - | 6.60B | 8.37B | 6.50B | 9.31B | 9.30B |
| Net Income | 404M | 2.56B | 2.46B | 2.91B | 4.34B | 5.59B | 4.50B | 6.67B | 6.26B |
| EPS | 46 | 295 | 283 | 393 | 508 | 655 | 528 | 782 | 734 |
| Balance Sheet | |||||||||
| Total Assets | 12.4B | 15.3B | 17.6B | 23.0B | 59.0B | 62.8B | 67.3B | 73.4B | 76.3B |
| Total Liabilities | 5.01B | 5.33B | 5.20B | 7.16B | 6.06B | 4.20B | 4.18B | 3.65B | 3.42B |
| Shareholders' Equity | 7.40B | 9.96B | 12.4B | 15.9B | 53.0B | 58.6B | 63.1B | 69.8B | 72.9B |
| Cash & Short-term Investments | 3.25B | 6.51B | 5.49B | 5.49B | 40.3B | 40.9B | 45.9B | 10.8B | 12.4B |
| Cash Flow | |||||||||
| Operating Cash Flow | 1.07B | 3.23B | 2.12B | 3.69B | 5.57B | 6.05B | 6.04B | 7.28B | 5.98B |
| Capital Expenditure | 1.13B | 283M | 1.89B | 7.02B | 152M | 2.33B | 1.30B | 1.05B | 625M |
| Free Cash Flow | - | - | 229M | -3.33B | 5.35B | 3.72B | 4.74B | 6.23B | 5.36B |
| Ratios | |||||||||
| ROE | 5.5% | 25.7% | 19.8% | 18.3% | 8.2% | 9.5% | 7.1% | 9.6% | 8.6% |
| ROA | 3.3% | 16.8% | 14.0% | 12.6% | 7.3% | 8.9% | 6.7% | 9.1% | 8.2% |
| Net Profit Margin | 6.7% | 30.2% | 28.5% | 24.3% | 27.3% | 35.8% | 28.0% | 34.8% | 33.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Bio-FD&C Co. Ltd. dividends
Bio-FD&C Co. Ltd. has not paid dividends in the last 8 fiscal years.
Who owns Bio-FD&C Co. Ltd.
- Insiders 40.26%
- Institutions 0.08%
- Public & others 59.66%
- Shares outstanding 8.53M
- Free float 5.09M
Bio-FD&C Co. Ltd. company profile
- Company name
- Bio-FD&C Co. Ltd.
- Ticker
- 251120.KQ
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Oil, Gas & Consumable Fuels
- Fiscal year end
- December
- Address
- 509, 510, and 511, A-dong, Smartvalley, Incheon, South Korea
- Phone
- 82 3 2811 2027
- Website
- biofdnc.com
About Bio-FD&C Co. Ltd.
BIO-FD&C Co.,Ltd. develops active ingredients for anti-aging cosmetics in South Korea. It offers plant cell, peptide, natural extract, and biomolecule products for wrinkle improvement/skin regeneration, skin brightening, acne, skin irritation, wound healing, scalp improvement, skin moisturizing, fine dust, hair loss improvement, pores, lifting, whitening, skin texture, anti-inflammation/skin soothing, and anti-oxidation. The company was founded in 2005 and is headquartered in Incheon, South Korea.
Bio-FD&C Co. Ltd. management
4- Mr. Sang-Hyun MoCo-CEO & Director · born 1975
- Mr. Dae-Hyeon JeongCo-CEO & Director · born 1972
- Mr. Changmyoung LeeHead of Management Support Division, CFO & Director · born 1976
- Ms. SuJeong KimMD & Executive Director · born 1978